Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 20/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8543842 | 1.00 | FKBP1A (0.59) | FKBP1A | |
| SCHEMBL8548538 | 1.00 | FKBP1A (0.59) | FKBP1A | |
| SCHEMBL8547438 | 0.87 | FKBP1A (0.54) | FKBP1A | |
| SCHEMBL8547442 | 0.87 | FKBP1A (0.54) | FKBP1A | |
| SCHEMBL8544850 | 0.87 | FKBP1A (0.54) | FKBP1A | |
| SCHEMBL8546853 | 0.85 | HTT (0.46) | FKBP1A | |
| SCHEMBL8546861 | 0.85 | HTT (0.46) | FKBP1A | |
| SCHEMBL8546856 | 0.85 | HTT (0.46) | FKBP1A | |
| SCHEMBL8543982 | 0.84 | FKBP1A (0.51) | FKBP1A | |
| SCHEMBL8541292 | 0.84 | FKBP1A (0.51) | FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0610744-B1 | Sulfonamide aminomethylene derivatives as immunosuppressants | BAYER AG (US) | 1998-11-04 | — | — | EP | claimed |
| US-5633277-A | ANTIINFLAMMATORY | MILES INC. (US) | 1997-05-27 | — | — | US | claimed |
| EP-0610744-A1 | Sulfonamide aminomethylene derivatives as immunosuppressants | Bayer Corporation (US) | 1994-08-17 | — | — | EP | claimed |
| EP-0610744-B1 | Sulfonamide aminomethylene derivatives as immunosuppressants | BAYER AG (US) | 1998-11-04 | — | — | EP | disclosed |
| EP-0610744-A1 | Sulfonamide aminomethylene derivatives as immunosuppressants | Bayer Corporation (US) | 1994-08-17 | — | — | EP | disclosed |